Literature DB >> 10569663

Outcomes of transcatheter valvotomy in patients with pulmonary atresia and intact ventricular septum.

J K Wang1, M H Wu, C I Chang, Y S Chen, H C Lue.   

Abstract

The results of transcatheter valvotomy in pulmonary atresia with intact ventricular septum (PA-IVS) patients are presented with an attempt to identify the predictive factors for pulmonary valvotomy alone as definitive treatment. Between June 1995 and December 1997, 14 PA-IVS neonates with tripartite right ventricle underwent an attempted pulmonary valvotomy. For perforation of the pulmonary valve, a guidewire was used in 4, and a radiofrequency guidewire in 10 patients. Two outcome groups were identified. Group I included those in whom transcatheter treatment achieved a definitive success; group II patients required surgery despite an initial successful valvotomy. The attempt failed in 3 patients, 1 of whom had pericardial effusion. Perforation of the pulmonary valve was achieved in 11 patients: 2 with a guidewire and 9 with a radiofrequency guidewire. A subsequent balloon valvuloplasty was performed in these 11 patients. After valvuloplasty, mean right ventricular pressure decreased from 124 +/- 24 to 60 +/- 15 mm Hg (p <0.01). One died of heart failure and infection 10 days later, despite successful weaning from prostaglandin E1. Group I patients (n = 6) were treated with transcatheter valvotomy alone. Group II patients (n = 4) required right ventricular outflow patch. Significant differences between the 2 groups (group I vs II) were identified in tricuspid valve Z value (0.52 +/- 0.37 vs -1.25 +/- 0.48, p <0.05), pulmonary valve Z value (-3.47 +/- 0.59 vs -5.43 +/- 0.94, p <0.05), and ratio of right-to-left ventricular area on the apical 4-chamber view (0.73 +/- 0.06 vs 0.49 +/- 0.03, p <0.05). There were no significant differences in hemodynamic characteristics between the 2 groups. After a follow-up period ranging from 7 to 35 months (mean 18 +/- 10.3), the most recent echocardiograms in the 10 patients showed a mean pressure gradient across the pulmonary valve of 17 +/- 15 mm Hg. All 10 patients had an oxygen saturation of >92%. Transcatheter valvotomy using a radiofrequency guidewire is a safe and effective treatment in selected patients with PA-IVS. Transcatheter valvotomy can be a definitive treatment in PA-IVS patients with a tricuspid valve Z value > or = -0.1, pulmonary valve Z value > or = -4.1 and ratio of right-to-left ventricular area > or = 0.65.

Entities:  

Mesh:

Year:  1999        PMID: 10569663     DOI: 10.1016/s0002-9149(99)00498-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Pulmonary Stenosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-12

2.  Evolution of the management approach for pulmonary atresia with intact ventricular septum.

Authors:  Y P Mi; A K T Chau; C S W Chiu; T C Yung; K S Lun; Y F Cheung
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

3.  A perforation procedure for pulmonary atresia with intact ventricular septum : Egyptian experience and adaptations.

Authors:  S A El Saiedi; W A Attia; O M Abd El-Aziz; W N Lotfy; A M Abd El-Rahim; H Hassanein; S Qureshi
Journal:  Herz       Date:  2017-08-23       Impact factor: 1.443

4.  Retrograde Pulmonary Vein Recanalization Using Transcatheter Electrosurgery.

Authors:  Saleem I Almasarweh; James A Kuo; Holly D Bauser-Heaton; Vasilis C Babaliaros; Dennis W Kim
Journal:  JACC Case Rep       Date:  2022-05-18

Review 5.  Transcatheter Electrosurgery: JACC State-of-the-Art Review.

Authors:  Jaffar M Khan; Toby Rogers; Adam B Greenbaum; Vasilis C Babaliaros; Dursun Korel Yildirim; Christopher G Bruce; Daniel A Herzka; William H Schenke; Kanishka Ratnayaka; Robert J Lederman
Journal:  J Am Coll Cardiol       Date:  2020-03-31       Impact factor: 24.094

6.  Outcomes in neonates with pulmonary atresia and intact ventricular septum underwent pulmonary valvulotomy and valvuloplasty using a flexible 2-French radiofrequency catheter.

Authors:  Meng-Luen Lee; Lon-Yen Tsao; Han-Yao Chiu; Ming Chen; Ing-Sh Chiu
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.